Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Company announcement – No. 45 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, September 12, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL)…
Innate Pharma S.A. (IPHA) Q2 2024 Earnings Call Transcript
Innate Pharma S.A. (NASDAQ: IPHA) Q2 2024 Earnings Conference Call September 12, 2024 8:00 AM ET Henry Wheeler - Vice President, Investor Relations and Communications Herve Brailly - Interim Chief Executive Officer Sonia Quaratino - Chief Medical…
Pharma companies' strategies for reaching poorer countries remain unclear
Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to…
'Major conflict': Chinese military-linked pharma corps make flurry of payments to taxpayer-funded scientists
A Chinese biotech company under fire from lawmakers over its ties to China's military and multiple other firms linked to the Chinese government have made dozens of payments to government scientists, records show. WuXi AppTec, which think tanks and…
This SME stock has surged 61% in 12 days; zoomed 328% in 3 months: Sudarshan Pharma share price
Shares of Sudarshan Pharma Industries were locked in upper circuit of 5 per cent at Rs 274.50, which is also the new high the stock created on the BSE in Thursday's intra-day trade on the back of a three-fold jump in average trading volumes. The…
How to keep the BIOSECURE Act from hobbling U.S. biotech and pharma
In a rare display of bipartisan agreement, Congress is getting serious about addressing China's influence in key industries. This spring's “TikTok ban” is the most obvious example of this effort. Legislation currently under debate…
EU GMP Certification sends this small-cap pharma stock flying over 14%: Medicamen Biotech share price
Medicamen Biotech shares zoom: Shares of pharmaceutical company, Medicamen Biotech, climbed as much as 14.29 per cent to Rs 507 on the BSE during intra-day deals on Thursday. The uptick in the stock price followed the news that the company's…
Nxera's Partner Cancer Research UK to Present on Phase 1/2a Clinical Trial with Cancer Immunotherapy Drug HTL0039732 at ESMO
HTL0039732 (also known as NXE0039732) is Nxera's novel oral EP4 antagonist with the potential to treat a wide range of cancers in combination with other immunotherapies Cancer Research UK's Centre for Drug Development is sponsoring and managing the…
Health Care Up on Cyclical Bias -- Health Care Roundup
Health-care companies rose, but not by as much as the broad market, as traders rotated into cyclical sectors. Pfizer shares fell after The Wall Street Journal reported that a key heart drug, marketed under the brand names Vyndaqel and Vyndamax…
Stock Market Today: Markets decline in early trade after record rally
Equity benchmark indices declined in early trade on Friday (September 13, 2024) after the previous session's record rally on the emergence of profit-taking amid weak trends from Asian peers. The 30-share Bombay Stock Exchange (BSE) Sensex dived…
Can microgravity improve the performance of pharmaceuticals?
A new collaborative project aims to assess how gravity influences the properties of molecules, which could lead ‘transform' the realms of materials and pharmaceuticals. Irish researchers have teamed up with US-based Varda Space Industries to…
The PIONeeR Project to Present Late-Breaking Results from its Phase Ib/IIa umbrella study at the ESMO Congress 2024
The PIONeeR Project to Present Late-Breaking Results from its Phase Ib/IIa umbrella study at the ESMO Congress 2024 The Presidential Symposium 'Eyes to the future' will feature the first-ever presentation of the clinical trial portion of the…
Charles River Labs to lay off 650 workers - Boston Business Journal
Charles River Laboratories International Inc. is now sharing how many jobs it expects to cut as it undergoes “restructuring initiatives” which it announced last month. A spokesperson for the Wilmington-based firm confirmed to the…
Amphastar: Perplexing Pipeline, Lumpy Revenues - I'm On Sidelines (NASDAQ:AMPH)
This is my first time providing coverage for Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), based in Rancho Cucamonga, California. The company completed its initial public offering ('IPO') in 2014, raising ~$41m via the issuance of ~5.84m shares…
Roche Shares Slump on Oral Weight-Loss Drug Candidate Side Effects
Roche's stock fell after new data from an early-stage clinical trial of its closely watched oral weight-loss drug candidate prompted analysts to question the company's potential to quickly enter a booming obesity market. Shares in the Swiss pharma…
Receive a Daily briefing on Pharma Industry News
Get Started